Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Beauchamp

Showing results (141-150 of 250) with videos related to

Pageof 25
Sort By:
Annals of Surgical Oncology|November 24, 1999
Nonoperative management of primary colorectal cancer in patients with stage IV diseaseC R Scoggins, I M Meszoely, C D Blanke, et al.
American Journal of Surgery|January 1, 1994
Transforming growth factor-beta inhibits rat intestinal cell growth by regulating cell cycle specific gene expressionT C Ko, R D Beauchamp, C M Townsend, et al.
Gastroenterology|June 1, 1993
Insulinlike growth factor-binding protein modulates the growth response to insulinlike growth factor 1 by human gastric cancer cellsY S Guo, R D Beauchamp, G F Jin, et al.
Chronobiology International|July 1, 1996
Day-night treatment difference of tobramycin serum and intrarenal drug distribution and nephrotoxicity in rats: effects of fastingL Lin, L Grenier, M LeBrun, et al.
Archives of Internal Medicine|June 1, 1982
Pericarditis in a patient with Legionnaires' diseaseB W Landes, G W Pogson, G D Beauchamp, et al.
The Journal of Biological Chemistry|August 15, 1998
Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathwayH Sheng, C S Williams, J Shao, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1994
Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in ratsL Lin, L Grenier, Y Bergeron, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1995
Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnetR F Omar, N Dusserre, A Désormeaux, et al.
Toxicology and Applied Pharmacology|March 1, 1997
Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS modelR F Omar, P Harvie, P Gourde, et al.
Annals of Surgery|October 1, 1986
Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitisW H Nealon, R D Beauchamp, C M Townsend, et al.
Pageof 25

Showing results (141-150 of 250) with videos related to

Sort By:
Pageof 25
Annals of Surgical Oncology|November 24, 1999
Nonoperative management of primary colorectal cancer in patients with stage IV diseaseC R Scoggins, I M Meszoely, C D Blanke, et al.
American Journal of Surgery|January 1, 1994
Transforming growth factor-beta inhibits rat intestinal cell growth by regulating cell cycle specific gene expressionT C Ko, R D Beauchamp, C M Townsend, et al.
Gastroenterology|June 1, 1993
Insulinlike growth factor-binding protein modulates the growth response to insulinlike growth factor 1 by human gastric cancer cellsY S Guo, R D Beauchamp, G F Jin, et al.
Chronobiology International|July 1, 1996
Day-night treatment difference of tobramycin serum and intrarenal drug distribution and nephrotoxicity in rats: effects of fastingL Lin, L Grenier, M LeBrun, et al.
Archives of Internal Medicine|June 1, 1982
Pericarditis in a patient with Legionnaires' diseaseB W Landes, G W Pogson, G D Beauchamp, et al.
The Journal of Biological Chemistry|August 15, 1998
Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathwayH Sheng, C S Williams, J Shao, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1994
Temporal changes of pharmacokinetics, nephrotoxicity, and subcellular distribution of tobramycin in ratsL Lin, L Grenier, Y Bergeron, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1995
Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnetR F Omar, N Dusserre, A Désormeaux, et al.
Toxicology and Applied Pharmacology|March 1, 1997
Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS modelR F Omar, P Harvie, P Gourde, et al.
Annals of Surgery|October 1, 1986
Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitisW H Nealon, R D Beauchamp, C M Townsend, et al.
Pageof 25